Business
Business, markets and economy
Business
Business group puts markers down for Space Force acquisition overhaul
Business group puts markers down for Space Force acquisition overhaul Business group puts markers down for Space Force a…
SpaceNews · 38 days ago
Business
'We're already fighting yesterday's battle': Greece's prime minister gets candid about AI | TechCrunch
Most leaders on a trade mission stick to the pitch, but when I interviewed Greek Prime Minister Kyriakos Mitsotakis this…
TechCrunch · 39 days ago
Business
Protests for Germany’s car industry as job losses loom
A combination of Chinese competition and US tariffs is causing problems in Germany.
Ars Technica · 39 days ago
Business
Robinhood’s Abhishek Fatehpuria joins Disrupt 2026 | TechCrunch
Robinhood’s Abhishek Fatehpuria on winning the modern financial consumer at TechCrunch Disrupt 2026. Register now to sav…
TechCrunch · 43 days ago
Business
Musk's long-time backer is giving SpaceX stock to its investors | TechCrunch
Valor Equity Partners is handing out stock to its LPs instead of cash returns.
TechCrunch · 45 days ago
Business
Companies defend Bromo joint venture
Executives with the three European companies seeking to combine their space businesses say the merger is still needed.
SpaceNews · 46 days ago
Business
StockWatch: Novartis Loses More than Market Value After Phase III Failure
Del-desiran was one of three clinical setbacks for Novartis within a week. On September 4, Novartis and Ionis Pharmaceut…
Genetic Engineering & Biotechnology News · —
Business
Larry Ellison cancels $7.5 billion sale of Oracle stock | TechCrunch
Oracle had previously disclosed that Ellison planned to sell 50 million shares worth around $7.5 billion.
TechCrunch · 48 days ago
Business
StockWatch: Insilico Projects Profit, Revenue Leaps as AI-Developed Lead Candidate Moves to Phase III
Insilico Medicine, an AI-based drug developer whose profile within biopharma has risen with its recent collaborations wi…
Genetic Engineering & Biotechnology News · —
Business
StockWatch: Axiom CEO Explains Plans for Hong Kong IPO
Axiom Biosciences founder, CEO, and chairman Remo Moomiaie-Qajar, MD, tells GEN why his company intends to trade its fir…
Genetic Engineering & Biotechnology News · 49 days ago
Business
StockWatch: Lilly Rises on Revenue Leap; Analysts High on Krystal Despite Revenue Miss
Thanks to its windfall of revenue from tirzepatide, the pharma giant reported second-quarter revenue and other results t…
Genetic Engineering & Biotechnology News · 49 days ago
Business
StockWatch: Revolution Shares Stay Flat Despite Historic FDA Approval of Oral Pancreatic Cancer Therapy
Revolution Medicines shares stayed relatively flat despite the FDA’s historic approval of the company’s oral pancreatic…
Genetic Engineering & Biotechnology News · 49 days ago